Clinical Trial Update: Assessment of Desogestrel in Ondine Syndrome [Phase 2, Phase 3]

View source ↗

Summary

This document reports the completion of Phase 2 and Phase 3 trials evaluating desogestrel for congenital central hypoventilation syndrome (Ondine syndrome).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Congenital Central Hypoventilation Syndrome

Drugs mentioned

• Desogestrel (Desogestrel)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Ondine Syndrome | Phase 2, Phase 3 | Status: COMPLETED